Antioxidants prevent the evolution of diabetic neuropathy by scavenging reactive oxygen species (ROS), regenerating endogenous and exogenous antioxidants, renovating oxidised proteins, inhibiting NF-kB and regulating gene transcription. Here, NFKB1 is linked to diabetic neuropathy.